Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

BACKGROUND: Tumour relapse is recognized to be the prime fatal burden in patients affected by head and neck squamous cell carcinoma (HNSCC), but no discrete molecular trait has yet been identified to make reliable early predictions of tumour recurrence. Expression of cell surface proteoglycans (PGs)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Farnedi, Anna, Rossi, Silvia, Bertani, Nicoletta, Gulli, Mariolina, Silini, Enrico Maria, Mucignat, Maria Teresa, Poli, Tito, Sesenna, Enrico, Lanfranco, Davide, Montebugnoli, Lucio, Leonardi, Elisa, Marchetti, Claudio, Cocchi, Renato, Ambrosini-Spaltro, Andrea, Foschini, Maria Pia, Perris, Roberto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4429505/
https://ncbi.nlm.nih.gov/pubmed/25935541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1336-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller